A detailed history of Kelly Financial Services LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Kelly Financial Services LLC holds 30 shares of IONS stock, worth $1,245. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30
Previous 30 -0.0%
Holding current value
$1,245
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Jul 17, 2024

SELL
$33.54 - $40.55 $39,141 - $47,321
-1,167 Reduced 97.49%
30 $1.01 Million
Q2 2021

Jul 17, 2024

BUY
$34.54 - $47.25 $19,584 - $26,790
567 Added 90.0%
1,197 $30,000
Q1 2021

Jul 17, 2024

SELL
$42.51 - $63.78 $14,368 - $21,557
-338 Reduced 34.92%
630 $28.3 Million
Q3 2019

Jul 17, 2024

SELL
$59.06 - $72.15 $1,889 - $2,308
-32 Reduced 3.2%
968 $58 Million
Q1 2019

Jul 17, 2024

BUY
$52.92 - $81.17 $52,920 - $81,170
1,000 New
1,000 $81.2 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.89B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Kelly Financial Services LLC Portfolio

Follow Kelly Financial Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kelly Financial Services LLC with notifications on news.